Medicare Enrolled

Dr. Bruce Friedman, M.D.

Critical Care Medicine · Augusta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3651 WHEELER RD, Augusta, GA 30909
7065044651
In practice since 2005 (20 years)
NPI: 1417939315 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Friedman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Friedman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Friedman

Dr. Bruce Friedman is a critical care medicine specialist in Augusta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Friedman performed 383 Medicare services across 114 unique beneficiaries.

Between the years covered by Open Payments, Dr. Friedman received a total of $797,943 from 40 pharmaceutical and/or device companies across 857 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Friedman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 383 Medicare services $797,943 industry payments

Medicare Practice Summary

Medicare Utilization ↗
383
Medicare services
Bottom 36% in GA for critical care medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
114
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~19 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
 216 $162 $740
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
 112 $88 $280
Arterial line insertion
A tube is inserted into an artery through the skin to allow for blood sampling or infusion.
 23 $34 $135
Insertion of non-tunneled central venous catheter
A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin.
 20 $64 $630
Ultrasound guidance for blood vessel access
Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood.
 12 $11 $65
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.2% high complexity
3.1% medium
91.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$797,943
Total received (2018-2024)
Avg $113,992/year across 7 years
Top 1% in GA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
857
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$758,057 (95.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$37,989 (4.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,896 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,706
2023
$95,104
2022
$126,179
2021
$88,201
2020
$45,895
2019
$221,239
2018
$200,618

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Shionogi Inc
$20,706
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Shionogi Inc
$157,577
La Jolla Pharmaceutical Company
$122,910
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$115,095
PORTOLA PHARMACEUTICALS, INC.
$105,816
AcelRx Pharmaceuticals, Inc.
$60,476
Melinta Therapeutics, Inc.
$48,369
Paratek Pharmaceuticals, Inc.
$46,678
Merck Sharp & Dohme Corporation
$24,762
Melinta Therapeutics, LLC
$24,208
Astellas Pharma US Inc
$23,253
Medline Industries, Inc.
$13,949
TETRAPHASE PHARMACEUTICALS, INC.
$11,215
PORTOLA PHARMACEUTICALS, LLC
$8,037
Collegium Pharmaceutical, Inc.
$6,034
AstraZeneca Pharmaceuticals LP
$5,431
Allergan, Inc.
$4,583
Merck Sharp & Dohme LLC
$3,463
Alexion Pharmaceuticals, Inc.
$3,450
Regeneron Healthcare Solutions, Inc.
$2,750
Mallinckrodt LLC
$2,604
C. R. BARD, INC. & SUBSIDIARIES
$2,510
Baudax Bio Inc.
$1,105
Allergan Inc.
$909
Bard Access Systems, Inc.
$600
Kerecis Limited
$477
BARD PERIPHERAL VASCULAR, INC.
$300
Cook Medical LLC
$282
Dr.Reddy's Laboratories,Inc.
$200
Bioventus LLC
$187
Avita Medical Americas, LLC
$157
CIPLA USA INC.
$147
Trevena, Inc.
$80
Milliken Healthcare Products, LLC
$67
Sientra, Inc.
$65
Smith+Nephew, Inc.
$58
Potrero Medical, Inc.
$40
MEDELA LLC
$34
BioFire Diagnostics, LLC
$29
BioXcel Therapeutics, Inc.
$21
Theravance Biopharma, Inc.
$15
Top 3 companies account for 49.6% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ANJESO · AVYCAZ · Andexxa · BEVYXXA · Baxdela · BioFire FilmArray · COOK MEDICAL AIRWAY MANAGEMENT · CRESEMBA · Cook Medical Centesis & Drainage · Cook Medical Enteral Nutrition · DIFICID · DSUVIA · Dermatology and Wound Care · Fetroja · GIAPREZA · IGALMI · Kerecis Omega3 SurgiClose · NUZYRA · OFIRMEV · OLINVYK · POWERGLIDE · PluroGel Burn & Wound Dressings · RELISTOR · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · SonicOne Clinic · VABOMERE · VIBATIV · Vabomere · Versajet · XERAVA · XIFAXAN · Xerava · Xtampza ER · ZEMDRI (PLAZOMICIN) · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for critical care medicine in GA.

Looking for a critical care medicine specialist in Augusta?
Compare critical care medicines in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
14
Per 100K population
6.8
County median income
$53,197
Nearest hospital
DOCTORS HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Friedman is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Friedman experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Friedman performed 216 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Friedman receive payments from pharmaceutical companies?
Yes. Dr. Friedman received a total of $797,943 from 40 companies across 857 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Friedman's costs compare to other critical care medicines in Augusta?
Dr. Friedman's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Friedman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Critical Care Medicines in Augusta
Browse critical care medicines in Augusta ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in GA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in GA
Which GA critical care medicines receive the most from drug and device companies.
By company
Shionogi Inc Payments to Doctors
See all physicians who received payments from Shionogi Inc.
By company
La Jolla Pharmaceutical Company Payments to Doctors
See all physicians who received payments from La Jolla Pharmaceutical Company.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →